Pseudotumor is an uncommon but severe complication in patients with hemophilia.
Introduction
Hemophilic pseudotumor is a rare but life-threatening complication in hemophilia. It occurs in about 1% to 2% of patients. In 1918, Starker first described these lesions as a slow progressive subperiosteal hemorrhage. When left untreated, they may destroy underlying tissues by progressive necrosis. 1 Usually, pseudotumors present as a chronic, slowly expanding, encapsulated cystic mass as a result of recurrent hemorrhage in extra-articular musculoskeletal system. Many patients recalled sustaining an injury prior to the development of the pseudotumor. Depending on the anatomic location of the lesions, pseudotumors are categorized as osseous and soft tissue lesions. 2 Treatment of hemophilic pseudotumors includes coagulation factor replaced therapy, radiotherapy, surgery, or combined therapy. 3, 4 To improve our knowledge on clinical diagnosis and management of hemophiliac pseudotumor, we analyzed the clinical feature, imaging finding, management, and outcome of pseudotumors of 14 patients at a single center.
Methods Patients
The medical records of 1248 patients with hemophiliac diagnosed between January 1983 and October 2004 at our hospital were reviewed and the medical records of 14 patients with hemophilia with pseudotumor were analyzed. Pseudotumor was diagnosed according to the clinical and radiological criteria described previously. 4, 5 The following data for patients with an established diagnosis of pseudotumor were analyzed: type and severity of hemophilia, recorded etiological antecedent, pseudotumor location, clinical symptoms and signs (local pain, mass volume, neurological symptoms, etc), imaging finding, treatment regimen, and outcome.
Definitions and Treatment Regimens
The different treatment regimens have been classified into 3 major types: (1) Replacement therapy, in which doses ranging from 10 to 30 U/kg were transfused once or twice per day. (2) Surgical therapy (including excision, incision drainage, and amputation). (3) Radiotherapy.
All surgical procedures were covered with replacement therapy. A bolus dose calculated is intended to raise the circulating factor level up to 50% to 80% according to the operation type before surgery, followed by the infusion per 12 hours for the first 3 days after surgery. Then the dose and frequency of replacement would decrease progressively according to the bleed of wound. If patient developed massive uncontrolled intraoperative bleeding, an additional bolus of coagulation factor would be given.
Results

Epidemiological and Clinical Data
There are 14 patients diagnosed as hemophilic pseudotumor among 1248 patients with hemophilia from January 1983 to October 2004 at our hospital. The incidence of pseudotumor in our single center is 1.12%.
All patients with pseudotumors are male with hemophilia A (decreased factor VIII:C [FVIII:C] and normal VWF:Ag). According to the FVIII:C levels, 8 patients (57.1%) have severe disease (FVIII: C<1%) and 6 patients (42.9%) have moderate disease (FVIII:C 1%-5%). The median age at presentation was 23.4 years (12-44 years). All patients had no FVIII inhibitor. The main clinical data are shown in Table 1 .
History of bleeding. In addition to the development of pseudotumor, 12 patients (85.7%) had history of one or several types of recurrent bleeding episodes: purpura, ecchymosis, joint bleeding, intramuscular bleeding, hematochezia, and hematuria.
Location and clinical manifestations of pseudotumors. Pseudotumor was confined to soft tissues in 2 patients (14.3%), and affecting bones in 12 patients (85.7%). Local pain, either spontaneous or induced, was present in 12 (85.7%). Thirteen patients (92.9%) had dysfunction of the pseudotumor, which affected local areas including impaired walking (12 patients, 85.7%, pseudotumor in calcaneus, lower leg, hallux, gluteus maximus, thigh, metatarsal bone) and dysfunction of hand grip (1 patient, 7.1%, pseudotumor in digitus annularis). One patient (7.1%) had paresthesia over the distal anterior aspect of the thigh and anterior aspect of the lower leg.
Etiological factor. Eight patients (57.1%) had history of injury prior to the development of pseudotumor while others did not. The courses of disease are present in Table 1 . Five of the 14 patients had history of surgical intervention of the lesions in other hospital prior to presentation to our hospital (discussed later).
Imaging Finding
The radiograph was performed in all patients and sonogram was performed in 2 patients, whereas computed tomography (CT) was performed in 2 patients. The main imaging finding included soft tissue swelling/lump accompanied with or without sporadic calcification, increased density of soft tissue, erosion of adjacent bone cortex, residual bone cortical sclerosis, saccular osteolytic lesion, osteoporosis of adjacent bone, disassociation of small cancellous bones, and tumor formation.
Therapy, Pathological Anatomy and Follow-Up
A total of 12 patients accepted 1 or 2 therapeutic regimens: replacement therapy, surgical therapy, or radiotherapy ( Table 1 ). Patient 10 had a surgical excision at other hospital where the pseudotumor was diagnosed as polyp. Macroscopically, the cyst was filled with blood-like material in various degrees of organization. Finally, in our hospital, he was diagnosed with hemophilia A with pseudotumor of the right maxillary sinus and was given replacement therapy and anti-infective therapy because of continual bleeding and disunion of the operative incision.
Surgical therapy was carried out in 6 patients in our hospital. Intractable pain, uncontrolled swelling, great mass, progressive osteolysis had been the reasons to implement surgical management. The remaining 3 patients underwent surgery after unsuccessful treatment with replacement therapy. All surgical therapy was covered with replacement therapy both preoperative and postoperative according to the type of operation.
Excision and curettage were performed in 2 patients. Both achieved resolution. Patient 6 underwent surgical therapy twice because of recurrence after the first surgical excision 4 months later. Macroscopically, there was a great mass with intact wall formation between the left deep fascia and the gluteus maximus. The left gluteus was compressed and formed a cavity of about 3 Â 5 cm 2 .
Amputation was carried out in patient 2, due to progressive osteolysis. Microscopically, there were fibrous proliferation with ossification, organization of hematoma, intense vascular neoformation, histiocyte proliferation, and hemosiderin deposition in truncate tissue.
Incision drainage and curettage was carried out in 3 patients. Macroscopically, cysts were composed of blood-like material in various degrees of organization and fibrous formation. The second management was carried out in patient 11 1 month later because of recurrent swelling. The wound healing remained incomplete with repeated bleeding requiring FVIII infusion once per week. An orificium fistula of 3 mm diameter was still present requiring FVIII infusion once per 2 to 4 weeks to prevent bleeding.
Radiotherapy accompanying discontinuous replacement therapy was carried out in patient 4 because the swelling of lesion was not relieved after 4 days of replacement therapy alone. He accepted 2000 rad radiation in 20 days, with regression of swelling and disappearance of pain.
Five patients accepted replacement therapy only. The wound of patient 5 healed with regression of swelling but the first interphalangeal joint malformation remained after continuous replacement therapy for 21 days. Two patients (respectively misdiagnosed with bone tumor and right maxillary sinus polyp) underwent surgical therapy at other hospital prior to presentation to our hospital. Replacement therapy was effective in hemostasis and wound healing.
Complication of surgery included fistula development in 1 patient, requiring regular replacement therapy for FVIII (once per 2-4 weeks). There were no infectious complications.
Up to now, 9 patients were lost to follow-up. Two patients (patients 2 and 7) died from causes unrelated to pseudotumor. Two patients (patients 4 and 6) remained remission and one (patient 11) remained orificium fistulae.
Discussion
Hemophilic pseudotumor has been observed in 1% to 2% of cases with severe hemophilia A and B by several groups. 4, 5 Although there is no wide agreement among authors in the management of pseudotumors, most authors indicate that therapy is ultimately dependent on a careful case-to-case evaluation. 4, 6, 7 In our series, the incidence is 1.12% similar to the reports of others. 4, 5 The proportion of severe patients in all our pseudotumor cases is 57.1%. Hemophilic pseudotumor may be misdiagnosed as tumor of bone or other system by only local signs and radiography, especially in those who do not have established hemophilia diagnosis. 8 In our series, 4 of 5 cases who underwent surgical procedure for a diagnosis of tumor did not have hemophilia A (2 severe and 2 moderate) as established diagnosis. In summary, it is important for a surgeon to inquire the history of bleeding and perform the basic studies including Activated partial thromboplastin time (APTT), prothrombin time (PT), fibrinogen, and thrombin time to exclude coagulopathies with pseudotumor. Magnetic resonance imaging (MRI) and CT scans may help with diagnosis, but they are expensive and may not be available in some hospitals of developing countries. 9 Gilbert has described 2 different clinical features for proximal and distal pseudotumors. 10 Proximal pseudotumors occur more frequently in the proximal axial skeleton, especially around the femur and the pelvis. In our series, 6 patients belong to this group. Distal pseudotumors occurred in 8 patients. These distal pseudotumors were particularly seen in the small cancellous and often caused by injury. Only 3 of 8 patients recalled prior trauma, it is estimated that trauma might have occurred without being recognized in the other 5 patients. The imaging finding usually reveal osteolysis and soft tissue swelling as have been reported by others. 11, 12 Although there is no agreement about the first-line therapy of pseudotumors, many investigators suggest poor result with only FVIII or FIX replacement therapy. The best result was usually achieved by surgical therapy. 4, 7, 13 In our series, 5 of 6 patients who underwent surgical therapy in our hospital achieved resolution without recurrence. One recurrence 4 months later had successful repeat surgical treatment. All of 6 patients were given replacement therapy preoperative and postoperative until wound healing. Percutaneous evacuation has been shown to have a high risk of continuous bleeding, recurrence, infection, and formation of a permanent fistula. 3 In our series, we performed incision drainage and scraping the cyst wall with curettage to clear the fibrous wall. Of the 3 patients, 2 achieved resolution and only 1 patient had a complication of fistula formation. Two patients (patients 11 and 14) who underwent surgical therapy in other hospital 2 months before presentation to our hospital and subsequently accepted replacement therapy only were included into the initial surgical therapy group in this series. One patient underwent combined replacement and radiotherapy, whereas replacement therapy alone could not control the left heel swelling. After 20 days irradiation, the swelling regressed and he regained walking ability. Subasi et al reported a successful case treated only with radiotherapy in 2007, in which pseudotumor occurred in the second and fifth fingers of the left hand of a 14-year-old young male. 14 These successful cases suggested that radiotherapy had a role in the treatment of pseudotumor. [14] [15] [16] In our series, only 1 of 3 patients who accepted replacement therapy as first and only therapy achieved obvious effect: healing of fistula, regression of soft tissues swelling but with persistent first interphalangeal joint malformation.
In conclusion, in our series, pseudotumor could develop either unprovoked or after trauma. Inadequate replacement after trauma contributes to the development of pseudotumor. Therapy of pseudotumor should be ultimately dependent on a careful case-to-case evaluation. Surgical therapy is safe and effective when covered with replacement therapy.
